These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 25456354)

  • 1. Non-coding RNAs as biomarkers for metastatic prostate cancer.
    Veltri WR
    Lancet Oncol; 2014 Dec; 15(13):1412-1413. PubMed ID: 25456354
    [No Abstract]   [Full Text] [Related]  

  • 2. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data.
    Cheng WS; Tao H; Hu EP; Liu S; Cai HR; Tao XL; Zhang L; Mao JJ; Yan DL
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3504-10. PubMed ID: 25491628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Going viral? Linking the etiology of human prostate cancer to the
    Teixeira AA; Marchiò S; Dias-Neto E; Nunes DN; da Silva IT; Chackerian B; Barry M; Lauer RC; Giordano RJ; Sidman RL; Wheeler CM; Cavenee WK; Pasqualini R; Arap W
    EMBO Mol Med; 2017 Oct; 9(10):1327-1330. PubMed ID: 28751581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
    Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
    Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
    Su YJ; Yu J; Huang YQ; Yang J
    Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: Risk SNPs modulate lncRNAs.
    Stone L
    Nat Rev Urol; 2016 Oct; 13(10):565. PubMed ID: 27578041
    [No Abstract]   [Full Text] [Related]  

  • 13. Long noncoding RNA: "LNCs" to cancer.
    Sültmann H; Diederichs S
    Eur Urol; 2014 Jun; 65(6):1152-3. PubMed ID: 24508069
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromoplexy and hypoxic microenvironment drives prostate cancer.
    Ballas LK; Hu BR; Quinn DI
    Lancet Oncol; 2014 Dec; 15(13):1419-1421. PubMed ID: 25456359
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer: Integrated test predicts outcome.
    Thoma C
    Nat Rev Urol; 2015 Jan; 12(1):7. PubMed ID: 25447834
    [No Abstract]   [Full Text] [Related]  

  • 17. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
    Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
    Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
    Arunkumar G; Deva Magendhra Rao AK; Manikandan M; Arun K; Vinothkumar V; Revathidevi S; Rajkumar KS; Rajaraman R; Munirajan AK
    Tumour Biol; 2017 Apr; 39(4):1010428317698366. PubMed ID: 28443494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.
    Cui W; Qian Y; Zhou X; Lin Y; Jiang J; Chen J; Zhao Z; Shen B
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S3. PubMed ID: 26100580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.